Xiaoguang Yang
Wenhua Road
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy.
Journal: International journal of pharmaceutics
Published: May 17, 2022
Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents.
Journal: Bioorganic & medicinal chemistry letters
Published: July 06, 2020
The Efficient Synthesis of Benzannulated Seven-Membered O-Heterocycles via the Intramolecular Ring-Opening Cyclization of Cyclopropanes.
Journal: Organic letters
Published: November 02, 2019
Design, Synthesis, and Mechanism of Dihydroartemisinin⁻Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents.
Journal: Molecules (Basel, Switzerland)
Published: April 06, 2019
Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Journal: Molecules (Basel, Switzerland)
Published: March 18, 2019
Repurposing antitubercular agent isoniazid for treatment of prostate cancer.
Journal: Biomaterials science
Published: November 24, 2018
Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 15, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026